The Senate Finance Committee today held for Alex Azar, President Trump鈥檚 nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. If confirmed, Azar said he would focus his efforts on addressing the high cost of drugs; making health care more affordable, available and 鈥渢ailored to what individuals want and need in their care鈥; harnessing 鈥渢he power of Medicare to shift the focus in our health care system from paying for procedures and sickness to paying for health and outcomes鈥; and tackling 鈥渢he scourge of the opioid epidemic.鈥 Tom Price, M.D., resigned as HHS secretary last September. Deputy Secretary Eric Hargan has been serving as acting secretary.

Related News Articles

Headline
The AHA has released several resources that can be used to educate members of Congress and community stakeholders about the potential effects of harmful cuts鈥
Perspective
Public
The House Energy & Commerce Committee in just over a week is expected to mark up its portion of the budget reconciliation bill to enact key pieces of鈥
Headline
A study published April 28 by Health Affairs Scholar found low-income adults living in states with Medicaid expansion experienced an average 9.5% relative鈥
Headline
The AHA April 30 released a report highlighting how hospitals and health systems continue to experience significant financial headwinds that can challenge鈥
News
The AHA April 29 urged majority and minority leaders in both the Senate and House to not make disruptive policy changes to Medicaid and other coverage options鈥
Perspective
Public
One year ago, a nurse at Children鈥檚 Hospital Colorado went above and beyond in a way that a very young patient and her family will never forget. Kayla鈥